| Display title | Company:Tengion |
| Default sort key | Tengion |
| Page length (in bytes) | 7,361 |
| Namespace ID | 3042 |
| Namespace | Company |
| Page ID | 837072 |
| Page content language | en - English |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| HandWiki item ID | None |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | imported>Steve Marsio |
| Date of page creation | 19:41, 9 February 2024 |
| Latest editor | imported>Steve Marsio |
| Date of latest edit | 19:41, 9 February 2024 |
| Total number of edits | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
Description | Content |
Article description: (description)
This attribute controls the content of the description and og:description elements. | Tengion, Inc. is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina. Its goals are discovering, developing, manufacturing and commercializing... |
